As at today Westpac Broking has 'No Recommendation'?? Pattersons are however still maintaining a 'Buy' high risk.Would be interested to see comment from Hartleys however.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%